Released Feb 19, 2021, during market hours
10-K filed Feb 19, 2021, 50 days after period end · 0001437749-21-003415
Q4 2020 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$259.83M$259.83M derived+2.3% vs Q4 2019+3.7% vs Q3 2020
Net Income$27.55M$27.55M derived+100.1% vs Q4 2019+114.4% vs Q3 2020
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived$12,779,000−22.5%
Operating Cash Flowderived$19,359,000−23.2%
Free Cash Flowderived$15,203,000−17.8%
Margins · derived
Operating margin4.9%−1.6 pt vs Q4 2019
Net margin10.6%+5.2 pt vs Q4 2019
What the release said
The release
Same quarter
| Metric | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 | Q4 2017 |
|---|---|---|---|---|
| Revenue | $259.83M | $253.88M | $248.92M | $246.31M |
| Net Income | $27.55M | $13.77M | $18.15M | $21.47M |
| EPS Diluted | — | $0.89 | $1.19 | $1.41 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Healthcare Corp · CIK 1047335 · Engraved from SEC EDGAR